Publication | Open Access

Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial

Phase 1/2Hematological MalignancyMyelodysplastic SyndromeMedicineMixed-phenotype Acute LeukemiaHematologyMyeloid NeoplasiaPharmacotherapyOncologyRadiation OncologyPhase 1Health Sciences